Equillium
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Equillium and other ETFs, options, and stocks.About EQ
Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6.
CEOBruce D. Steel
CEOBruce D. Steel
Employees35
Employees35
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2017
Founded2017
Employees35
Employees35
EQ Key Statistics
Market cap96.85M
Market cap96.85M
Price-Earnings ratio-2.03
Price-Earnings ratio-2.03
Dividend yield—
Dividend yield—
Average volume524.93K
Average volume524.93K
High today$1.44
High today$1.44
Low today$1.23
Low today$1.23
Open price$1.34
Open price$1.34
Volume555.11K
Volume555.11K
52 Week high$2.35
52 Week high$2.35
52 Week low$0.27
52 Week low$0.27
Stock Snapshot
With a market cap of 96.85M, Equillium(EQ) trades at $1.26. The stock has a price-to-earnings ratio of -2.03.
As of 2025-12-13, Equillium(EQ) stock has fluctuated between $1.23 and $1.44. The current price stands at $1.26, placing the stock +2.4% above today's low and -12.5% off the high.
Equillium(EQ) shares are trading with a volume of 555.11K, against a daily average of 524.93K.
In the last year, Equillium(EQ) shares hit a 52-week high of $2.35 and a 52-week low of $0.27.
In the last year, Equillium(EQ) shares hit a 52-week high of $2.35 and a 52-week low of $0.27.
People also own
Based on the portfolios of people who own EQ. This list is generated using Robinhood data, and it’s not a recommendation.